Heron Therapeutics Inc. (HRTX)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
Q2  2023 | |||||
≡ | Meridian Contrarian Fund | Sell 100.00% | 1,277,424 | 0.35 | |
Q4  2022 | |||||
≡ | Meridian Contrarian Fund | Reduce 42.05% | 431,000 | 0.20 | |
Q4  2021 | |||||
≡ | Meridian Contrarian Fund | Reduce 6.98% | 52,790 | 0.07 | |
Q2  2020 | |||||
≡ | Meridian Contrarian Fund | Reduce 15.73% | 50,000 | 0.16 | |
Q1  2020 | |||||
≡ | Meridian Contrarian Fund | Reduce 5.92% | 20,000 | 0.06 | |
Q4  2019 | |||||
≡ | Meridian Contrarian Fund | Reduce 20.10% | 85,000 | 0.36 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.